1. Home
  2. ZVIA vs GOSS Comparison

ZVIA vs GOSS Comparison

Compare ZVIA & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevia PBC

ZVIA

Zevia PBC

HOLD

Current Price

$1.26

Market Cap

96.4M

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.34

Market Cap

88.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVIA
GOSS
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.4M
88.6M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
ZVIA
GOSS
Price
$1.26
$0.34
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
$4.93
$4.19
AVG Volume (30 Days)
335.8K
6.8M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
55.88
N/A
EPS
N/A
N/A
Revenue
$161,259,000.00
$48,471,000.00
Revenue This Year
$8.30
N/A
Revenue Next Year
$6.87
$201.64
P/E Ratio
N/A
N/A
Revenue Growth
4.01
N/A
52 Week Low
$1.11
$0.32
52 Week High
$3.66
$3.87

Technical Indicators

Market Signals
Indicator
ZVIA
GOSS
Relative Strength Index (RSI) 50.84 33.42
Support Level $1.12 $0.33
Resistance Level $2.78 $0.47
Average True Range (ATR) 0.06 0.04
MACD 0.02 0.02
Stochastic Oscillator 59.46 12.33

Price Performance

Historical Comparison
ZVIA
GOSS

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: